ASML Holding highlights lithography demand, shares track sector moves

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-26, 07:08.

ASML Holding N.V. (NL0010273215) continues to be one of the most closely watched semiconductor equipment names on Euronext Amsterdam. Investor focus stays on the order outlook for extreme ultraviolet (EUV) systems and the timing of a broader recovery in chip capital expenditure, as recent sector commentary from peers such as TSMC and Samsung underscores a cautious but improving demand backdrop. Recent Reuters coverage on global chip capex trends helps frame expectations for ASML in this context.

What recent data suggest on chip demand

Recent industry data indicate that wafer fab equipment spending remains below prior peaks but shows signs of stabilization, particularly in leading-edge logic and foundry segments where customers like TSMC, Intel and Samsung are progressing with 3 nm and 2 nm nodes. For ASML, this environment matters because EUV lithography tools are essential for these advanced nodes, and each individual EUV system carries a price tag that can exceed 200 million euros, making even a small change in unit demand significant for revenue. Financial Times reporting on EUV equipment spending has highlighted how these high-value tools concentrate sector investment.

On NASDAQ and in Europe, semiconductor stocks including ASML, ASMI and Lam Research have recently traded in tandem with broader chip indices such as the Philadelphia Semiconductor Index, reflecting investor sensitivity to incremental data on PC, smartphone and data center demand. For ASML, movements in these peers help signal how markets discount the pace of recovery in memory and logic spending, even before the company provides its next formal trading update.

How analysts view ASML right now

Analyst sentiment on ASML remains broadly constructive, with a majority of covering houses rating the stock at Buy or equivalent according to recent consensus data from market platforms that track European blue chips. Large investment banks such as Goldman Sachs, Morgan Stanley and UBS have in past months emphasized ASML's dominant market position in EUV lithography and the visibility provided by its order backlog, even while flagging near-term volatility in shipments and regional export restrictions as central risks. Recent Morgan Stanley commentary on ASML's EUV outlook illustrates this combination of structural optimism and cyclical caution.

Consensus expectations for the coming years typically assume that ASML can grow revenue as high-NA EUV tools move from development into broader volume production, and as demand for mature-node deep ultraviolet (DUV) systems stabilizes or recovers with automotive, industrial and IoT applications. At the same time, analysts watch closely how export control measures affecting shipments to China might influence the regional mix of sales and the timing of certain orders, a factor that has already led to periodic adjustments in individual price targets and earnings models.

What ASML sells in lithography

ASML generates most of its revenue by developing and manufacturing photolithography systems that chip makers use to pattern circuits on silicon wafers, with a portfolio that includes EUV tools for the most advanced nodes and deep ultraviolet (DUV) systems for a wide range of applications. A flagship product line is the NXE series of EUV scanners, which enables the high-resolution patterning required for leading-edge processors in smartphones, PCs and data center servers. ASML's own product description of the NXE EUV systems outlines their role in enabling chip scaling.

Where the stock trades today

ASML Holding N.V. shares trade on Euronext Amsterdam under the ticker ASML, most recently quoted around 850.00 euros in regular trading as of 2026-06-26, 09:00, according to exchange data.

This article was produced with AI assistance and editorially reviewed. Price and company figures without guarantee; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions carry risks up to and including total loss.